List of Veterinary Master File (VMF) of Dextran 70 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

Data Compilation
#PharmaFlow

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

Stock Recap
#PipelineProspector

Dextran 70

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 8 USDMF, 4 CEP/COS, 3 JDMF, 6 NDC API, 1 VMF, 4 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 11 Europe, 6 Canada, 4 South Africa, 4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 2 Nanjing Well Pharmaceutical, 8 Actylis, 1 BASF, 3 Finar, 3 Gangwal Chemicals, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 6 Seppic

EXCIPIENTS BY APPLICATIONS

16 Parenteral, 12 Solubilizers, 5 Topical, 3 Emulsifying Agents, 3 Fillers, Diluents & Binders, 2 API Stability Enhancers, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Disintegrants & Superdisintegrants